Orthopedic and Traumatologic Surgery Dept, Maison Blanche Hospital, Reims University Hospital, 45, rue Cognacq-Jay, 51100 Reims, France.
Orthop Traumatol Surg Res. 2011 Feb;97(1):51-7. doi: 10.1016/j.otsr.2010.09.016. Epub 2011 Jan 26.
Non-union is presently managed exclusively by surgery, but alternative treatments are under evaluation.
To assess the benefit of external ultrasound stimulation in surgically treated lowerlimb long-bone non-union.
A retrospective series of 14 patients were treated using the Exogen(®) ultrasound stimulator (Smith & Nephew Inc., Memphis, TN, USA) as part of management of surgically treated long-bone non-union. They received 20min stimulation daily over a period of 3 months. Regular clinical and radiological follow-up checked treatment efficacy.
The mean interval to initiation of Exogen(®) treatment after initial surgery was 361 days (range, 6, 38 months). Bone consolidation was obtained in 11 of the 14 cases (79%), and within 3 months of initiation of Exogen(®) treatment in 27% (3/11), within 6 months in 27% (3/11) and within 9 months in 46% (5/11). There were no treatment-linked complications. There was no significant correlation between interval to initiation of ultrasound treatment and bone consolidation. Associated sepsis or atrophy did not significantly impact treatment efficacy.
The reference treatment strategy in non-union is surgical revision, with consolidation rates ranging from 85 to 100% according to the series. This attitude entails risk of complications, notably infection and postoperative pain. The present results were comparable to those of the literature, with 79% bone consolidation and no complications. Ultrasound stimulation proved an effective and non-invasive treatment for non-union.
Retrospective study, level IV.
目前,非愈合完全通过手术治疗,但正在评估替代治疗方法。
评估体外超声刺激对手术治疗下肢长骨非愈合的益处。
回顾性系列研究共纳入 14 例患者,使用 Exogen(®)超声刺激器(Smith & Nephew Inc.,Memphis,TN,USA)作为手术治疗长骨非愈合的治疗方法之一。他们每天接受 20 分钟的刺激,持续 3 个月。定期进行临床和影像学随访,以检查治疗效果。
在初始手术后开始使用 Exogen(®)治疗的平均时间间隔为 361 天(范围,6-38 个月)。14 例患者中有 11 例(79%)获得骨愈合,其中 27%(3/11)在开始使用 Exogen(®)治疗后 3 个月内,27%(3/11)在 6 个月内,46%(5/11)在 9 个月内。治疗过程中无相关并发症。超声治疗开始时间与骨愈合之间无显著相关性。伴发的感染或萎缩并未显著影响治疗效果。
非愈合的参考治疗策略是手术翻修,根据系列研究结果,其愈合率在 85%至 100%之间。这种治疗方法存在并发症风险,尤其是感染和术后疼痛。本研究结果与文献报道相似,骨愈合率为 79%,且无并发症。超声刺激被证明是非愈合的一种有效且非侵入性的治疗方法。
回顾性研究,IV 级。